ATCC: Defense Threat Reduction Agency grants
ATCC, a biological materials management and standards organization, has landed three grants totalling more than $5.5m from the Defense Treat Reduction Agency (DTRA). The work reportedly will center on identifying and characterizing novel therapeutic approaches to viruses with potential global health concern.
"ATCC is committed to supporting this global health initiative by providing the novel scientific research and development solutions needed to address these high-morbidity and mortality infectious disease outcomes," said Raymond Cypess, chairman and CEO of ATCC. “Through our new partnership with DTRA, we now have the opportunity to focus on the development of novel machine learning (ML) and artificial intelligence (AI) models for countermeasure identification that may lead to better vaccine and therapeutic solutions, which are needed to save lives."